Analytical Data
-
基因名
GKN2
- Application
-
别名
GKN2；BLOT；GDDR；TFIZ1；Gastrokine-2
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q86XP6
-
表达区间
21-184aa
-
氨基酸序列
YEVFNIISPS NNGGNVQETV TIDNEKNTAI INIHAGSCSS TTIFDYKHGY IASRVLSRRA CFILKMDHQN IPPLNNLQWY IYEKQALDNM FSSKYTWVKY NPLESLIKDV DWFLLGSPIE KLCKHIPLYK GEVVENTHNV GAGGCAKAGL LGILGISICA DIHV
-
分子量
20.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GKN2 (Gastric Kinesin 2) is a member of the GKN family of proteins, which are notably associated with gastric mucosal defense and repair processes. The interest in GKN2 has surged due to its potential role in various gastrointestinal diseases, including gastric cancer, chronic gastritis, and peptic ulcers. Studies have shown that GKN2 exhibits anti-inflammatory properties and is crucial for maintaining mucosal integrity in response to injury or infection. Moreover, altered expression levels of GKN2 have been linked to the disease progression in gastric conditions, prompting research into its molecular mechanisms and potential as a therapeutic target. Recent investigations involve the production of recombinant GKN2 proteins to study their structure, function, and interactions with other biomolecules. By utilizing advanced cloning and expression techniques, researchers aim to produce sufficient quantities of this protein for functional assays, structural characterization, and potential drug development. Understanding the role of GKN2 in gastric pathophysiology could pave the way for novel therapeutic strategies and biomarkers for early diagnosis in gastric diseases. Thus, the study of recombinant GKN2 is a promising area of research that bridges basic science and clinical applications, offering insights into gastric health and disease management.
